Health FDA accepts nirsevimab application as first Globe News Wire Jan 5, 2023 FDA accepts nirsevimab application as first protective option against RSV disease for all infants Nirsevimab would be the first broadly protective option against RSV disease designed for all infants, if approvedNirsevimab delivered…
